rs377415279
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001184880.2(PCDH19):c.3204C>T(p.Pro1068Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000596 in 1,208,982 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000064 ( 0 hom. 28 hem. )
Consequence
PCDH19
NM_001184880.2 synonymous
NM_001184880.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.03
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-100296520-G-A is Benign according to our data. Variant chrX-100296520-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 393107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.03 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 28 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH19 | NM_001184880.2 | c.3204C>T | p.Pro1068Pro | synonymous_variant | 6/6 | ENST00000373034.8 | NP_001171809.1 | |
PCDH19 | NM_001105243.2 | c.3063C>T | p.Pro1021Pro | synonymous_variant | 5/5 | NP_001098713.1 | ||
PCDH19 | NM_020766.3 | c.3060C>T | p.Pro1020Pro | synonymous_variant | 5/5 | NP_065817.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH19 | ENST00000373034.8 | c.3204C>T | p.Pro1068Pro | synonymous_variant | 6/6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
PCDH19 | ENST00000255531.8 | c.3063C>T | p.Pro1021Pro | synonymous_variant | 5/5 | 1 | ENSP00000255531.7 | |||
PCDH19 | ENST00000420881.6 | c.3060C>T | p.Pro1020Pro | synonymous_variant | 5/5 | 1 | ENSP00000400327.2 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111238Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33410
GnomAD3 genomes
AF:
AC:
2
AN:
111238
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33410
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000111 AC: 2AN: 180986Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67018
GnomAD3 exomes
AF:
AC:
2
AN:
180986
Hom.:
AF XY:
AC XY:
1
AN XY:
67018
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000638 AC: 70AN: 1097744Hom.: 0 Cov.: 30 AF XY: 0.0000771 AC XY: 28AN XY: 363112
GnomAD4 exome
AF:
AC:
70
AN:
1097744
Hom.:
Cov.:
30
AF XY:
AC XY:
28
AN XY:
363112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111238Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33410
GnomAD4 genome
AF:
AC:
2
AN:
111238
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Developmental and epileptic encephalopathy, 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 04, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at